|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005684,
umls-concept:C0008838,
umls-concept:C0010651,
umls-concept:C0013089,
umls-concept:C0013216,
umls-concept:C0025677,
umls-concept:C0026845,
umls-concept:C0030705,
umls-concept:C0035020,
umls-concept:C0035647,
umls-concept:C0042670,
umls-concept:C0205281,
umls-concept:C0449774,
umls-concept:C1280500,
umls-concept:C1518988
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2000-5-2
|
|
pubmed:abstractText |
Trials have demonstrated decreased relapse with perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) chemotherapy in patients with muscle invasive bladder cancer. We evaluated whether the benefit of chemotherapy correlates with its effects on distant or pelvic relapse.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
163
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1413-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10751847-Aged,
pubmed-meshheading:10751847-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10751847-Cisplatin,
pubmed-meshheading:10751847-Combined Modality Therapy,
pubmed-meshheading:10751847-Cystectomy,
pubmed-meshheading:10751847-Disease-Free Survival,
pubmed-meshheading:10751847-Doxorubicin,
pubmed-meshheading:10751847-Female,
pubmed-meshheading:10751847-Humans,
pubmed-meshheading:10751847-Male,
pubmed-meshheading:10751847-Methotrexate,
pubmed-meshheading:10751847-Middle Aged,
pubmed-meshheading:10751847-Muscle, Smooth,
pubmed-meshheading:10751847-Muscle Neoplasms,
pubmed-meshheading:10751847-Neoplasm Invasiveness,
pubmed-meshheading:10751847-Neoplasm Metastasis,
pubmed-meshheading:10751847-Neoplasm Recurrence, Local,
pubmed-meshheading:10751847-Neoplasm Staging,
pubmed-meshheading:10751847-Retrospective Studies,
pubmed-meshheading:10751847-Risk Factors,
pubmed-meshheading:10751847-Treatment Failure,
pubmed-meshheading:10751847-Urinary Bladder Neoplasms,
pubmed-meshheading:10751847-Vinblastine
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
|
|
pubmed:affiliation |
Department of Radiation Oncology, College of Physicians and Surgeons, School of Public Health, Columbia University, New York, New York, USA.
|
|
pubmed:publicationType |
Journal Article
|
